Recurrent Glioblastoma: Where we stand

Current first-line treatment regimens combine surgical resection and chemoradiation for Glioblastoma that provides a slight increase in overall survival. Age on its own should not be used as an exclusion criterion of glioblastoma multiforme (GBM) treatment, but performance should be factored heavily...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Sanjoy, Lahiri, Debarshi, Maji, Tapas, Biswas, Jaydip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
NEURO ONCOLOGY: Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772393/
https://www.ncbi.nlm.nih.gov/pubmed/26981507
http://dx.doi.org/10.4103/2278-330X.175953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772393/
https://www.ncbi.nlm.nih.gov/pubmed/26981507
http://dx.doi.org/10.4103/2278-330X.175953

Ejemplares similares